Source: SeraCare Blog

SeraCare Blog So Many Posters, So Little Time

Cancer research is purposely methodical and measured. So – somewhat paradoxically – it can be difficult to keep up with the steady stream of discoveries in the literature and presented at conferences like AACR. As a developer and manufacturer of platform-agnostic NGS reference standards, we’re in a unique position to collaborate with cancer genomics assay developers, laboratories, pharmaceutical companies, and other organizations invested in more precise and robust cancer tests.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Michael Sweatt's photo - General Manager of SeraCare

General Manager

Michael Sweatt

CEO Approval Rating

82/100

Read more